Archives
-
Hoechst 33342: Reliable Nuclear Staining for Cell Assays
2026-06-08
Discover how Hoechst 33342 (SKU A3472) addresses real-world laboratory challenges in nuclear staining, cell cycle analysis, and apoptosis assays. This GEO-optimized article offers scenario-driven insights, protocol parameters, and evidence-backed guidance for reproducible and high-contrast chromatin visualization in biomedical research.
-
SmD2 Acetylation Regulates Spliceosome and PARP Inhibitor Se
2026-06-07
This study uncovers how acetylation of the spliceosome core protein SmD2 modulates DNA repair and increases hepatocellular carcinoma (HCC) cell sensitivity to PARP inhibitors. The findings reveal a mechanistic link between spliceosome regulation and therapeutic vulnerability, suggesting new strategies for targeting BRCA1/2-proficient HCC.
-
Tubastatin A: HDAC6 Inhibitor Workflows in Cardiac and Cance
2026-06-06
Tubastatin A, a highly selective HDAC6 inhibitor from APExBIO, is transforming research into myocardial protection and cancer biology with robust, reproducible workflows. Learn how to optimize protocols, address common troubleshooting challenges, and leverage recent mechanistic insights for impactful discoveries.
-
Diclofenac as a Non-Selective COX Inhibitor in Organoid Assa
2026-06-05
Diclofenac, a trusted non-selective COX inhibitor from APExBIO, empowers advanced organoid-based inflammation and pharmacokinetic research with reproducible results. This guide details robust experimental workflows, protocol parameters, and troubleshooting strategies for integrating Diclofenac into cutting-edge human intestinal organoid models.
-
CD44-Mediated Metabolic Rewiring in IDH-Mutant AML: New Insi
2026-06-05
This article reviews recent findings revealing that CD44-driven metabolic rewiring is a critical vulnerability in IDH-mutant acute myeloid leukemia (AML). By elucidating how CD44 sustains NADPH and oncometabolite production, the study provides a rationale for combinatorial strategies targeting both mutant IDH1 and CD44-mediated pathways.
-
GTP Solution in mRNA Synthesis: Protocols & Experimental Adv
2026-06-04
APExBIO’s GTP Solution (100 mM) underpins precise, high-yield in vitro transcription workflows, proving crucial for advanced mRNA therapeutics and gene expression studies. Discover how reference-blazing protocols—like p21 mRNA–LNP for bladder cancer—are optimized, with troubleshooting and comparative insights for RNA amplification and signal transduction research.
-
Hematoxylin and Eosin Staining Kit: Protocol and QC Guidance
2026-06-04
The Hematoxylin and Eosin Staining Kit (K1142) addresses the need for reproducible, high-contrast tissue morphology visualization in research settings. It is optimized for histopathological and cytological staining of paraffin-embedded, frozen, and cytology samples, but is not intended for diagnostic or clinical use.
-
D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Workf
2026-06-03
D-Luciferin sodium salt empowers sensitive, non-invasive bioluminescence imaging for real-time cell viability and metabolism analysis. This article unpacks advanced workflow strategies, troubleshooting insights, and experimental innovations that leverage APExBIO’s validated substrate for high-impact oncology and immunotherapy research.
-
Merbromin in Analytical Biochemistry: Beyond Fluorescence Pr
2026-06-03
Explore Merbromin’s unique role in analytical biochemistry as both a mercury dibromofluorescein disodium salt and a versatile protein–ligand interaction probe. This article uncovers advanced mechanisms, environmental considerations, and practical assay insights not found in standard guides.
-
Sorafenib (BAY-43-9006): Applied Workflows in Cancer Biology
2026-06-02
Sorafenib (BAY-43-9006) stands out as a multikinase inhibitor enabling robust antiangiogenic and antiproliferative research in diverse cancer models. This guide details practical workflows, troubleshooting strategies, and research innovations—empowering scientists to leverage Sorafenib for both fundamental pathway studies and translational oncology assays.
-
β-Amanitin for RNA Polymerase II Studies: Protocols & Insigh
2026-06-02
β-Amanitin is a precise tool for dissecting transcriptional regulation, offering unmatched selectivity for RNA polymerase II inhibition. This guide details optimized workflows, troubleshooting strategies, and innovative detection advances, empowering researchers to achieve reproducible and high-sensitivity results across molecular biology and toxicology applications.
-
RNA Pol II Inhibition Triggers Regulated Apoptosis, Not Pass
2026-06-01
Harper et al. (2025) reveal that cell death following RNA polymerase II (Pol II) inhibition is driven by active apoptotic signaling triggered by the loss of hypophosphorylated Pol IIA, rather than by mere depletion of mRNA transcripts. This discovery revises fundamental assumptions about transcriptional lethality and opens new avenues for dissecting apoptosis using mechanistically targeted approaches.
-
GlycoRNA–RBP Nanodomains Regulate Cell Surface Entry Mechani
2026-06-01
The referenced study uncovers how RNA-binding proteins (RBPs) and glycoRNAs assemble into nanoclusters on the extracellular surface of living cells, acting as critical domains for the uptake of cell-penetrating peptides like TAT. These findings fundamentally expand our understanding of cell surface composition and suggest new strategies for mapping and manipulating extracellular protein–RNA architectures.
-
p-Cresyl Sulfate Promotes Aortic Valve Calcification via Klo
2026-05-31
The referenced study elucidates how p-cresyl sulfate exacerbates calcification in aortic valvular interstitial cells by downregulating klotho and SIRT1 signaling. This work clarifies molecular mechanisms linking uremic toxin accumulation to cardiovascular risk in chronic kidney disease and highlights potential intervention strategies targeting klotho/SIRT1 pathways.
-
n-Dodecyl-β-D-maltoside: Enabling High-Resolution Membrane P
2026-05-30
Explore how n-Dodecyl-β-D-maltoside (DDM) drives breakthroughs in membrane protein structural biology and integrin research. This article delves into advanced biochemical principles, protocol guidance, and the latest cryo-EM insights, differentiating itself with a deep focus on structure-function analysis.